Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Narod

Showing results (141-150 of 544) with videos related to

Pageof 55
Sort By:
Hereditary Cancer in Clinical Practice|March 2, 2018
Frequency of <i>BRCA1</i> and <i>BRCA2</i> causative founder variants in ovarian cancer patients in South-East PolandTomasz Kluz, Andrzej Jasiewicz, Elżbieta Marczyk, et al.
Breast Cancer Research and Treatment|November 2, 2005
Influence of selected lifestyle factors on breast and ovarian cancer risk in BRCA1 mutation carriers from PolandJacek Gronwald, Tomasz Byrski, Tomasz Huzarski, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 19, 2003
The N314D polymorphism of galactose-1-phosphate uridyl transferase does not modify the risk of ovarian cancerW L Alan Fung, Harvey Risch, John McLaughlin, et al.
Breast Cancer Research and Treatment|July 24, 2014
Prevalence of women with early-stage breast cancer receiving active management using electronic health records from oncology clinics in the United StatesRohini K Hernandez, David Quach, Sally W Wade, et al.
Gynecologic Oncology|August 20, 2010
Risk factors for non-invasive lesions of the fallopian tube in BRCA mutation carriersDanielle Vicus, Patricia A Shaw, Amy Finch, et al.
Human Mutation|October 29, 2002
A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer familiesCatherine M Phelan, Elaine Kwan, Elaine Jack, et al.
JAMA Network Open|August 8, 2019
Changes in Bone Mineral Density After Prophylactic Bilateral Salpingo-Oophorectomy in Carriers of a BRCA MutationJoanne Kotsopoulos, Elizabeth Hall, Amy Finch, et al.
Gynecologic Oncology|November 3, 2011
BRCA1 and BRCA2 mutations among ovarian cancer patients from ColombiaAlexandra Ortiz Rodríguez, Marcia Llacuachaqui, Gonzalo Guevara Pardo, et al.
Breast Cancer Research and Treatment|September 15, 2010
A high prevalence of BRCA1 mutations among breast cancer patients from the BahamasTalia Donenberg, John Lunn, Duvaughn Curling, et al.
Breast Cancer Research and Treatment|November 1, 2016
Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panelOlivia Moran, Dina Nikitina, Robert Royer, et al.
Pageof 55

Showing results (141-150 of 544) with videos related to

Sort By:
Pageof 55
Hereditary Cancer in Clinical Practice|March 2, 2018
Frequency of <i>BRCA1</i> and <i>BRCA2</i> causative founder variants in ovarian cancer patients in South-East PolandTomasz Kluz, Andrzej Jasiewicz, Elżbieta Marczyk, et al.
Breast Cancer Research and Treatment|November 2, 2005
Influence of selected lifestyle factors on breast and ovarian cancer risk in BRCA1 mutation carriers from PolandJacek Gronwald, Tomasz Byrski, Tomasz Huzarski, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 19, 2003
The N314D polymorphism of galactose-1-phosphate uridyl transferase does not modify the risk of ovarian cancerW L Alan Fung, Harvey Risch, John McLaughlin, et al.
Breast Cancer Research and Treatment|July 24, 2014
Prevalence of women with early-stage breast cancer receiving active management using electronic health records from oncology clinics in the United StatesRohini K Hernandez, David Quach, Sally W Wade, et al.
Gynecologic Oncology|August 20, 2010
Risk factors for non-invasive lesions of the fallopian tube in BRCA mutation carriersDanielle Vicus, Patricia A Shaw, Amy Finch, et al.
Human Mutation|October 29, 2002
A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer familiesCatherine M Phelan, Elaine Kwan, Elaine Jack, et al.
JAMA Network Open|August 8, 2019
Changes in Bone Mineral Density After Prophylactic Bilateral Salpingo-Oophorectomy in Carriers of a BRCA MutationJoanne Kotsopoulos, Elizabeth Hall, Amy Finch, et al.
Gynecologic Oncology|November 3, 2011
BRCA1 and BRCA2 mutations among ovarian cancer patients from ColombiaAlexandra Ortiz Rodríguez, Marcia Llacuachaqui, Gonzalo Guevara Pardo, et al.
Breast Cancer Research and Treatment|September 15, 2010
A high prevalence of BRCA1 mutations among breast cancer patients from the BahamasTalia Donenberg, John Lunn, Duvaughn Curling, et al.
Breast Cancer Research and Treatment|November 1, 2016
Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panelOlivia Moran, Dina Nikitina, Robert Royer, et al.
Pageof 55